Evidence map›Paper›PMID 34588984›Full record

ArticleFrontiers in pharmacology2021

CircRNA Microarray Profiling Reveals hsa_circ_0058493 as a Novel Biomarker for Imatinib-Resistant CML.

An-Ni Zhong, Yi Yin, Bing-Jie Tang, Lei Chen, Hong-Wei Shen, Zhi-Ping Tan, Wen-Qun Li, Qun He, Bao Sun, Yan Zhu and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. The theragnostic advances of exosomes in managing leukaemia.Journal of cellular and molecular medicine · 2024
    Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Recent Progress of CircRNAs in Hematological Malignancies.International journal of medical sciences · 2024
    Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Non-Coding RNAs Are Implicit in Chronic Myeloid Leukemia Therapy Resistance.International journal of molecular sciences · 2022
    Review
  20. Exosomal RNAs: Novel Potential Biomarkers for Diseases-A Review.International journal of molecular sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

An-Ni ZhongDepartment of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China.
Yi YinDepartment of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China.
Bing-Jie TangDepartment of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China.
Lei ChenDepartment of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China.
Hong-Wei ShenMedical Experiment Research Centre, The Second Xiangya Hospital, Central South University, Changsha, China.
Zhi-Ping TanDepartment of Cardiovascular Surgery, The Second Xiangya Hospital, Central South University, Changsha, China.
Wen-Qun LiDepartment of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China.
Qun HeDepartment of Hematology, Xiangya Hospital, Central South University, Changsha, China.
Bao SunDepartment of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China.
Yan ZhuDepartment of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China.
Jie XiaoDepartment of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China.
Zhi-Ping JiangDepartment of Hematology, Xiangya Hospital, Central South University, Changsha, China.
Ping XuDepartment of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China.
Central South University · CNSecond Xiangya Hospital of Central South University · CNXiangya Hospital Central South University · CNGuangxi Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

chronic myelogenous leukemiadrug resistanceexosomehsa_circ_0058493imatinib

Identifiers

PMID34588984
PMCPMC8473700
OpenAlexW3201581875

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.